Current report filing

Note 3 - Discontinued Operations - Discontinued Operations (Details)

v3.8.0.1
Note 3 - Discontinued Operations - Discontinued Operations (Details) - USD ($)
 12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net $ 1,598,994 $ 3,692,747  
Disposal Group, Including Discontinued Operation, Inventory 1,374,618 652,906  
Prepaid expenses 170,635 172,585  
Assets associated with discontinued operations, current 3,144,247 4,518,238  
Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Noncurrent 70,973 151,412  
Patents and trademarks, net of accumulated amortization 34,282 39,473  
Assets associated with discontinued operations, noncurrent 105,255 190,885  
Total assets associated with discontinued operations 3,249,502 4,709,123  
Disposal Group, Including Discontinued Operation, Accounts Payable, Current 1,957,938 242,220  
Disposal Group, Including Discontinued Operation, Accrued Liabilities, Current 607,659 859,365  
Deferred revenue 2,300,000  
Liabilities associated with discontinued operations, current 4,865,597 1,101,585  
Other liabilities 1,000,000  
Total liabilities associated with discontinued operations 4,865,597 2,101,585  
Lymphoseek sales revenue 16,997,497 10,235,277 $ 4,220,753
Disposa Group, Including Discontinued Operation, Royalty Revenue 1,194,660
Grant and other revenue 575 669
Total revenue 16,998,072 11,430,606 4,220,753
Cost of goods sold 2,234,780 1,751,537 1,583,519
Gross profit 14,763,292 9,679,069 2,637,234
Research and development 1,744,496 2,225,004 1,662,611
Selling, general and administrative 5,093,529 6,369,183 6,016,087
Total operating expenses 6,838,025 8,594,187 7,678,698
Income (loss) from discontinued operations 7,925,267 1,084,882 (5,041,464)
Interest expense (14,856,404) (5,603,820) (326,337)
Loss from discontinued operations $ (6,931,137) $ (4,518,938) $ (5,367,801)